By Associated Press July 2, 2009 | Comments (0)
Recs
Shares of some top biotechnology companies are down at 10 a.m.:
Amgen fell $.74 or 1.4 percent, to $52.02.
Biogen Idec fell $.64 or 1.4 percent, to $46.13.
Celgene fell $1.42 or 3.0 percent, to $46.68.
Gilead Sciences fell $.63 or 1.3 percent, to $46.20.
Read/Post Comments (0) | Recommend This Article (0) Recommended 0 Times
Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.
Your Fool username will be displayed with your comment. Please be respectful with your comments. Review our Fool's Rules.
Javascript is required to comment on Fool articles.
DocumentId: 933478, ~/Articles/ArticleHandler.aspx, 12/2/2009 2:52:50 PM
Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.
By The Motley Fool
Capital budgeting: Capital budgeting is the process businesses use to evaluate the future profitability of proposed projects, so that they can best determine where to allocate limited capital funds.
Want to learn more or edit this definition? Click here to read more!
Terms & Conditions
RSS Headlines
Fool UK